Drug Production Wuxi STA Breaks Ground for New Pharma Manufacturing Facility in USA

Source: Press release Wuxi STA

Related Vendors

Wuxi STA recently conducted a breaking ground ceremony for establishing the firm’s second pharma manufacturing facility in the USA. The first phase of the project will provide formulation development, clinical and commercial drug product manufacturing services.

Wuxi STA holds a groundbreaking ceremony for its new 190-acre pharmaceutical manufacturing campus in Middletown, USA.
Wuxi STA holds a groundbreaking ceremony for its new 190-acre pharmaceutical manufacturing campus in Middletown, USA.
(Source: Wuxi STA)

Shanghai/China – Wuxi STA, a leading Contract Research, Development, and Manufacturing Organization (CRDMO), has recently announced the breaking ground ceremony for its new 190-acre pharmaceutical manufacturing campus in Middletown, Delaware, USA. First announced in June 2021, this site will be Wuxi STA’s second facility in the United States, offering expanded capacity and greater flexibility to meet the needs of customers in the U.S. and around the world.

The new state-of-the-art facility will create approximately 500 full-time jobs by 2026. Phase I of the new campus will provide formulation development, clinical and commercial drug product manufacturing services for a variety of oral and injectable dosage forms, as well as packaging, labeling, storage and distribution services for clinical trial materials and commercial drug products.

Together with three other drug product manufacturing sites in Couvet (Switzerland), Wuxi City (China) and Shanghai (China), this new facility will further enhance the company’s global drug production capacity and capabilities.

The Wuxi STA Middletown facility is expected to begin operations in 2025.

(ID:48549074)

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy.

Unfold for details of your consent